Curie.Bio, the biotech accelerator and investment firm, has raised another $340 million to invest in startups.

In this way, these virtual biotechs are able to find a market for these compounds, since blockbusters and biosimilars are not as feasible for smaller biotech organizations. "The realities of the ...

While 2024 was a "challenging" year for biotech stocks, JPMorgan is of the view that some names in the industry may be poised for considerable upside in the coming months.

Maze Therapeutics said on Thursday that it raised $140 million in an initial public offering, setting the stage for a debut that could make the kidney disease drug developer the first U.S. biotech ...

In this opinion piece, Sylvia Wulf, the Biotechnology Innovation Organization’s interim head of agriculture and environment, ...

Robert F. Kennedy Jr. may soon be America's top pharmaceutical regulator. That is cause for concern in Seattle’s biotech ...

The Biotechnology Innovation Organization (BIO) was formed that year and now stands as the largest biotech trade organization in the world. BIO has spent millions lobbying the U.S. for small ...

GO Virginia approved a $14.3 million funding package to three Virginia biotech accelerator organizations in response to a multiregional proposal called “Project VITAL: Virginia Innovations and ...

While 2024 was a “challenging” year for biotech stocks, JPMorgan is of the view that some ... such as contract research organizations (CROs), contract manufacturing organizations (CMOs), and companies ...

YZi Labs announced it changed its company name from Binance Labs to operate independently. The firm will expand its ...

Investors have been closely monitoring Trinity Biotech's financial health and market position, as the company grapples with the headwinds that have led to this decline. With a significant debt burden ...